Add to Favorites Newsroom RSS Share
fb-shareLudwig Cancer Research
New York, NY USA

Our News on Newswise

Newswise: ScreenShot2020-02-14at1.54.17PM.png

Targeting Turncoat Immune Cells to Treat Cancer

A Ludwig Cancer Research study has identified a mechanism by which regulatory T cells, which suppress immune responses, adapt their metabolism to thrive in the harsh microenvironment of the tumor.
17-Feb-2020 11:00 AM EST Add to Favorites

Building a Safer CAR-T Therapy

A Ludwig Cancer Research study has devised a new type of chimeric antigen-receptor (CAR) T cell—a family of promising immunotherapies for cancer—that can be switched on and off on demand.
3-Feb-2020 11:20 AM EST Add to Favorites

Newswise: RDSFormaltight.jpg

Robert Schreiber Joins the Ludwig Institute's Scientific Advisory Committee

Ludwig Cancer Research extends a warm welcome to Robert Schreiber, the newest member of the Scientific Advisory Committee of the Ludwig Institute for Cancer Research.
31-Jan-2020 9:00 AM EST Add to Favorites

Newswise: DouglasHanahan.png

Douglas Hanahan Appointed Distinguished Scholar of the Ludwig Institute for Cancer Research

Ludwig Cancer Research is pleased to announce the appointment of Douglas Hanahan as a Distinguished Scholar at the Lausanne Branch of the Ludwig Institute for Cancer Research.
14-Jan-2020 3:00 AM EST Add to Favorites

Newswise: RELEASEPing-Chih.png

Ping-Chih Ho Appointed Associate Member of Ludwig Institute for Cancer Research

Ludwig Cancer Research congratulates Ping-Chih Ho on his appointment as Associate Member at the Lausanne Branch of the Ludwig Institute for Cancer Research.
9-Jan-2020 3:00 AM EST Add to Favorites

Newswise: ping.png

Ludwig Lausanne’s Ping-Chih Ho Named an EMBO Young Investigator

Ludwig Cancer Research congratulates Ping-Chih Ho on his selection by the European Molecular Biology Association (EMBO) as a member of its Young Investigator Programme.
13-Nov-2019 6:00 AM EST Add to Favorites

Newswise: NatureBiotech.png

Ludwig Researchers Develop Machine Learning Tool to Refine Personalized Immunotherapy

Ludwig Cancer Research scientists have developed a new and more accurate method to identify the molecular signs of cancer likely to be presented to helper T cells, which stimulate and orchestrate the immune response to tumors and infectious agents.
14-Oct-2019 12:00 PM EDT Add to Favorites

Newswise: BigP.jpeg

Ludwig Oxford’s Sir Peter Ratcliffe Wins Nobel Prize

Ludwig Cancer Research congratulates Peter Ratcliffe on his receipt of the 2019 Nobel Prize for Physiology or Medicine. He was recognized by the Nobel Committee for his landmark discoveries on the mechanisms by which mammalian cells sense and...
7-Oct-2019 4:30 PM EDT Add to Favorites


see all news

Our Experts on Newswise

Our experts are coming soon...

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact member@newswise.com to configure this module.

About

Ludwig Cancer Research is an international collaborative network of acclaimed scientists that has pioneered cancer discoveries for more than 40 years. Ludwig combines basic research with the ability to translate its discoveries and conduct clinical trials to accelerate the development of new cancer diagnostics and therapies. Since 1971, Ludwig has invested more than $2.5 billion in life-changing cancer research through the not-for-profit Ludwig Institute for Cancer Research and the six U.S.-based Ludwig Centers.

Contacts

Emily Akpan
Junior Account Executive

emily@gga.nyc

347-728-2910

Sara Cott
Senior Account Executive

sara@globalgatewayadvisors.com

Carol Harrison
Senior Partner
cancer medicine

carol@gga.nyc

917-860-9499

Rachel Steinhardt
Vice President for Communications
cancer medicine

rsteinhardt@licr.org

212-450-1582

Our Multimedia on Newswise

Twitter twitter-icon

Chat now!
0.53701